Positron emission tomography-computed tomography evaluation for recurrent differentiated thyroid carcinoma.

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Differentiated thyroid cancer (DTC) recurrence affects 15-20% of patients post-treatment.
• Dedifferentiation can lead to iodine-negative recurrences, complicating detection.
• Novel diagnostic methods are crucial for localizing these elusive recurrences.

Purpose of the Study:

• To review the utility of positron emission tomography-computed tomography (PET-CT) in identifying iodine-negative recurrent DTC.
• To assess PET-CT's effectiveness in cases where standard iodine imaging fails.

Main Methods:

• A comprehensive literature review and discussion were conducted.
• Analysis focused on studies evaluating PET-CT for recurrent DTC detection.

Main Results:

• PET-CT demonstrates sensitivity ranging from 70% to 85% with up to 90% specificity.
• A significant drawback is the potential for false negatives, reaching up to 40%.
• PET-CT influences therapeutic strategy changes in approximately 50% of patients with elevated thyroglobulin and no iodine uptake.

Conclusions:

• Thorough diagnostic work-up is essential for DTC recurrence, impacting patient survival.
• PET-CT serves as a valuable complementary tool for localizing recurrence when thyroglobulin is elevated and iodine scans are negative.